BDR Pharmaceuticals eyes controlling stake in Acme Formulation

PAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder and managing director Viral Shah retained a significant minority stake after the transaction and continued as managing director and CEO. PAG owns about 62% of the company, while Shah holds around 31%, with the balance is owned by other investors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JmlhNyz
via IFTTT

Read More

Andhra Pradesh teams up with AstraZeneca for next-gen cancer care model

Andhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial intelligence and advanced genomics for cancer care. The collaboration aims to transform patient journeys from screening to follow-up. AstraZeneca will deploy AI-powered solutions for early lung cancer detection. An Integrated Genomic Solutions Centre will expand access to advanced cancer diagnostics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/icoxMLN
via IFTTT

Read More

Alembic Pharma gets USFDA approval for generic chronic constipation treatment tablets

Alembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of one and two milligrams. These tablets are indicated for treating chronic idiopathic constipation in adults. The approved drug is therapeutically equivalent to Takeda's Motegrity tablets. This market segment has an estimated size of one hundred million dollars.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wv8WLxY
via IFTTT

Read More

Sakar Healthcare posts Rs 10-crore profit in Q1

Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also saw a significant rise during the same period. Its oncology business remains a key strategic focus for the pharmaceutical manufacturer. Sakar Healthcare executed numerous oncology product contracts and has many discussions ongoing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZGICO6T
via IFTTT

Read More

Centre readies healthcare compliance overhaul to boost hospitals in tier-2, tier-3 cities

India plans major healthcare regulatory changes soon. These reforms aim to simplify licensing and reduce compliance burdens. The government will release a consultation paper within two months. This initiative seeks to encourage private investment in smaller cities. The goal is to improve healthcare access across the nation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CrMLy1Q
via IFTTT

Read More

PHC Mogla brings healthcare closer to Rajouri's remote villages

PHC Mogla now offers essential healthcare services locally. Residents previously traveled long distances for basic medical treatment. A portable X-ray machine aids emergency care for injured patients. Maternal healthcare has also seen significant local improvements. This facility has become a crucial lifeline for remote villagers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0d3FwBE
via IFTTT

Read More

US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts

US pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market reliance. There are warnings that ensuring patient access to affordable medications should remain paramount.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yst4R6k
via IFTTT

Read More